๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for FL Lymphoma

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study NCT05846763n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma NCT07121946Phase 16 sites๐Ÿ“ Duarte๐Ÿ“ St Louis๐Ÿ“ Buffalo LTZ Therapeutics, Inc. ยท Tests: LTZ-301, LTZ-301, LTZ-301 SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites๐Ÿ“ Denver๐Ÿ“ Atlanta๐Ÿ“ Fairway Verismo Therapeutics ยท Tests: SynKIR-310 A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma NCT03460977Phase 185 sites๐Ÿ“ Tucson๐Ÿ“ Tucson๐Ÿ“ Tucson Pfizer ยท Tests: Mevrometostat (PF-06821497), Enzalutamide, Itraconazole Intracranial Genetically Modified Immune Cells (TGFฮฒR2KO/IL13Rฮฑ2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma NCT06815029Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Chimeric Antigen Receptor T-Cell Therapy, Echocardiography, Fludeoxyglucose F-18, Intracranial โ€ฆ Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial NCT06948786Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Pirtobrutinib, Mosunetuzumab, Biospecimen Collection, Biopsy Procedure, Computed Tomography Long-term Follow up Local Registry Study of Kymriah in South Korea NCT06785818n/a18 sites๐Ÿ“ Bundang Gu๐Ÿ“ Seongnam-si๐Ÿ“ Gyeonggi-do Novartis Pharmaceuticals ยท Tests: Tisagenlecleucel A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. NCT06022029Phase 116 sites๐Ÿ“ Los Angeles๐Ÿ“ Tamarac๐Ÿ“ Canton OncoNano Medicine, Inc. ยท Tests: ONM-501, Cemiplimab Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer NCT07215910Phase 3152 sites๐Ÿ“ Bakersfield๐Ÿ“ Duarte๐Ÿ“ Dublin Alliance for Clinical Trials in Oncology ยท Tests: Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Pencil Beam Scanning, Intensity-Modulated Proton Tโ€ฆ Abemaciclib in Newly Diagnosed Meningioma Patients NCT05940493Phase 21 site๐Ÿ“ Phoenix Nader Sanai ยท Tests: Abemaciclib, Placebo Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas NCT07468136Phase 1, Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Eflornithine, Lumbar Puncture, Magnetic Resonance Imaging, Retifanlimab Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) NCT07197307Phase 234 sites๐Ÿ“ Aachen๐Ÿ“ Augsburg๐Ÿ“ Berlin Universitรคt Mรผnster ยท Tests: Loncastuximab Tesirine and Epcoritamab Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader NCT05294731Phase 1, Phase 229 sites๐Ÿ“ Bengbu๐Ÿ“ Hefei๐Ÿ“ Beijing BeOne Medicines ยท Tests: Tacabrutideg Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of Therapy, Within the Compassionate Use Program (CUP). NCT07278921n/a1 site๐Ÿ“ Milan Andrรฉs Josรฉ Maria Ferreri ยท Tests: Mosunetuzumab Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites๐Ÿ“ Fort Myers๐Ÿ“ Indianapolis๐Ÿ“ Cleveland Frantz Viral Therapeutics, LLC ยท Tests: Artesunate ointment, Placebo ointment Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma NCT06528847Phase 21 site๐Ÿ“ Shanghai Shanghai Pulmonary Hospital, Shanghai, China ยท Tests: Benmelstobart Evaluate the Safety and Clinical Activity of HH2853 NCT04390737Phase 1, Phase 225 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Haihe Biopharma Co., Ltd. ยท Tests: HH2853 Tablets Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL NCT06151080Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: Lenalidomide combined with G-CHOP (LO CHOP) A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma NCT07562022Phase 31 site๐Ÿ“ Beijing Sinocelltech Ltd. ยท Tests: SCTB35 injection, Rituximab, Lenalidomide A Study of APG-3288 in Relapsed/Refractory Blood Cancers NCT07424833Phase 16 sites๐Ÿ“ Los Angeles๐Ÿ“ Jacksonville๐Ÿ“ Grand Rapids Ascentage Pharma Group Inc. ยท Tests: APG-3288 NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19) NCT07502118Phase 2, Phase 34 sites๐Ÿ“ Ankara๐Ÿ“ Ankara๐Ÿ“ Ankara Health Institutes of Turkey ยท Tests: Talikabtagene Autoleucel Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL NCT06287398Phase 21 site๐Ÿ“ Melbourne Australasian Leukaemia and Lymphoma Group ยท Tests: Epcoritamab Zanubrutinib Combined With G-CVP in Previously Untreated FL NCT06959732Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: zanubrutinib, obinutuzumab,combined with CVP Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma NCT06410248Phase 11 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Magnetic Resonance Imaging, Questionnaire Administration, Resection, Temozolomide Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma NCT06553352Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: Zanubrutinib combined with Obinutuzumab A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies NCT04830137Phase 116 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-2127 A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies NCT05131022Phase 162 sites๐Ÿ“ Duarte๐Ÿ“ San Francisco๐Ÿ“ Denver Nurix Therapeutics, Inc. ยท Tests: NX-5948 Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4 NCT06797219NA2 sites๐Ÿ“ Newark๐Ÿ“ Newark Rutgers, The State University of New Jersey ยท Tests: Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma NCT07428616Phase 220 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ San Francisco Exelixis ยท Tests: Zanzalintinib Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy NCT05255354n/a1 site๐Ÿ“ Palo Alto Adaptive Biotechnologies ยท Tests: ClonoSEQ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy